Universal Biosensors, Inc (ASX:UBI) Share Price and News

Market Cap (20-Mar) $21,758,892 (725th)	Close (30-Jun) $0.260 0 (0%)	Volume (30-Jun) 239,872	Shortsold (5-Oct) 64,772 (0.03%) (542nd)
52w High $0.220	52w Low $0.069	P/E -	EPS -0.05

	Subject
	UBI UBI Ann: Results of 2023 Annual General meeting
	1 (current) 2 3
	UBI UBI Ann: CEO's AGM address to Securityholders
	UBI UBI Ann: Q1 2023 Results
	UBI UBI Ann: UBI launches PETRACKR Diabetes product for dogs and cats
	UBI UBI Ann: Change in substantial holding
	UBI UBI Ann: Notification of cessation of securities - UBI
	UBI UBI Ann: March 2023 Quarterly Activity Report and Appendix 4C
	UBI UBI Ann: UBI launch sixth new Sentia Test
	UBI UBI Ann: Notice of Meeting/Proxy Statement
	UBI UBI Ann: UBI submits Xprecia Prime 510K Application to FDA
	UBI UBI Ann: Appendix 3Y - Graham McLean
	UBI UBI Ann: FY2022 Corporate Governance Statement & Appendix 4G
	UBI UBI Ann: FY2022 Corporate Governance Statement and Appendix 4G
	UBI UBI Ann: UBI Investor Presentation FY2022
	UBI UBI Ann: Appendix 4E and Annual Report on Form 10-K FY2022
	UBI UBI Ann: UBI launch another new Sentia Test
	UBI UBI Ann: Change in substantial holding
	UBI UBI Ann: UBI makes first sales of Xprecia Prime in Europe
	UBI UBI Ann: UBI launches new product - Fructose Test for Sentia
	UBI UBI Ann: December 2022 Quarterly Activity Report and Appendix 4C
	UBI UBI Ann: UBI completes Xprecia Prime clinical trial in USA
	UBI UBI Ann: UBI appoints a new Chairman
	UBI UBI Ann: Application for quotation of securities - UBI
	UBI UBI Ann: Notification of cessation of securities - UBI
	UBI UBI Ann: Appendix 3Y - Graham McLean
	UBI UBI Ann: UBI receives $3.9M under the R&D Tax Incentive Rebate
	UBI UBI Ann: UBI's Cancer Biomarker work gets published by ACS Sensors
	UBI UBI Ann: Appendix 3Y - Craig Coleman
	UBI UBI Ann: UBI Investor Presentation
	UBI UBI Ann: Change of Registry Address
	UBI UBI Ann: Q3 2022 Results Presentation
	UBI UBI Ann: September 2022 Quarterly Activity Report and Appendix 4C
	UBI UBI Ann: Market Update
	UBI UBI Ann: Change of Director's Interest Notice
	UBI UBI Ann: Half Year Results Presentation - 30 June 2022
	UBI UBI Ann: Appendix 4D and Half year Results - 30 June 2022
	UBI UBI Ann: New distribution deals in Europe and Glucose Test launch
	UBI UBI Ann: June 2022 Quarterly Activity Report & Appendix 4C
	UBI UBI Ann: Form 605 - JM Financial Group Ltd and No Plan B Pty Ltd
	UBI UBI Ann: Notification of cessation of securities - UBI
	UBI UBI Ann: Becoming a substantial holder
	UBI UBI Ann: Appendix 3Y - Judith Smith
	UBI UBI Ann: Results of 2022 Annual General Meeting
	UBI UBI Ann: CEO's AGM Address to Securityholders
	UBI UBI Ann: Form 604 - JM Financial Group Ltd
	UBI UBI Ann: Appendix 3Y - Craig Coleman
	UBI UBI Ann: Ceasing to be a substantial holder
	UBI UBI Ann: Appendix 3Y - Graham McLean
	UBI UBI Ann: Form 604 - Jencay Capital Pty ltd
	UBI UBI Ann: Form 604 - Viburnum Funds Pty Ltd

Similar Companies

Atomo Diagnostics

AT1

Cochlear

COH

CleanSpace Holdings

CSX

Cyclopharm

CYC

EMvision Medical Devices

EMV

Imagion Biosystems

IBX

ImpediMed

IPD

Micro-X

MX1

Respiri

RSH

SomnoMed

SOM

End of Day Prices

Date	Close	Volume	Change
19-Mar	$0.07	0	0.00 (0.00%)
18-Mar	$0.07	124,421	+0.00 (1.39%)
17-Mar	$0.07	429,316	0.00 (0.00%)
14-Mar	$0.07	28,865	+0.00 (2.86%)
13-Mar	$0.07	165,798	0.00 (5.41%)
12-Mar	$0.07	47,486	+0.00 (4.23%)
11-Mar	$0.07	35,000	0.00 (1.39%)
06-Mar	$0.07	0	0.00 (0.00%)
05-Mar	$0.07	68,850	0.00 (0.00%)
04-Mar	$0.07	5,368	0.00 (4.00%)
03-Mar	$0.08	142,203	+0.00 (5.63%)
28-Feb	$0.07	41,164	0.00 (1.39%)
27-Feb	$0.07	47,311	0.00 (0.00%)
26-Feb	$0.07	38,527	0.00 (0.00%)
25-Feb	$0.07	251,408	0.00 (4.00%)
4 up, 5 down, and 6 flat days

High $0.26	Low $0.22	Trades 21	Turnover $59,559	Volume 239,872
30 June 2023 at 4:10pm

High $0.26	Low $0.22	Trades 21	Turnover $59,559	Volume 239,872
30 June 2023 at 4:10pm

Universal Biosensors, Inc Health Care

$0.260 0.035 (15.56%)

$0.260 0.035 (15.56%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices